Back to Noidecs or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Strain Estimate)

Alpha-PineneMinorPine/Sharp156℃
Beta-PineneMinorPine/Herbal165℃
MyrceneMajorHerbal/Musk166-168℃
LimoneneMajorCitrus/Sour177℃

MedBud currently tracks 16 common terpenes, 24 more pending addition.

No full terpene profile has been provided for this product, information above may be estimated based on public strain information.

Dosing Look-Up Table (Estimated)

0.01/g1.7/mg THCTrace CBD
0.05/g8.5/mg THCTrace CBD
0.1/g17/mg THCTrace CBD
0.15/g25.5/mg THCTrace CBD
0.2/g34/mg THCTrace CBD
0.25/g42.5/mg THCTrace CBD
0.3/g51/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
United Kingdom Noidecs
Designation
T17
Cultivar/Strain
Night Queen
Classification
Indica
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
15.3-18.7%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Australia Cannatrek
Cultivated or Packaged in
Flag of Australia Australia
Irradiation
Gamma-Irradiated
Imported by
United Kingdom Eaststone
Imported as
Schedule II: Finished Product

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Discontinued

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Product Description Video Reviews0 Patient Reviews

About Night Queen

NQIndica

A typical classic 'Afghani-Kush' aroma, very powerful and pungent. She has a rich, thick and strong smell of hash when smoked.

Dutch Flag Dutch Bred, Afghani Flag Afghani Genetics

Night Queen has a typical classic 'Afghani-Kush' aroma, very powerful and pungent. She has a rich, thick and strong smell of hash when smoked. The aroma is best described as earthy mixed with notes of pine, incense and fruit. The Afghan heritage from the Mazar-i-Sharif Mountains makes for a compact plant with very hard white buds.

There are also phenotypes that are a bit sweeter and fruity with a light earthy background. These phenotypes are also incredibly powerful and give a heavy effect when smoked in a joint, a characteristic that suits cannabis strains from this region.

The buds get quite thick and dense, some are really "rock-hard" after drying and will bounce off the table if you drop them. In short, a classic Dutch Passion Indica dominant auto to love!

Description provided by: Dutch Passion

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Lyphe Group Ltd

Noidecs Logo

From Lyphe Group, a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.

At Lyphe our vertical operations span product manufacturing, clinical care, pharmacy dispensing and doctor education. Our direct-to-patient and technology-led approach has quickly established us as the market’s largest player, with a 30% share of all patients. We have also recently entered the Australian market, where we intend to replicate our model of success.

lyphegroup.com

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)